Joshua Adam Barocas, MD
Adjunct Assistant Professor, Medicine
Biography
I lead an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders, and other vulnerable populations. My research, which uses clinical epidemiology, health economics, simulation modeling, and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. I am engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for infections. My research is currently been funded by NIDA in the form of both a K01 and a DP2 award as well as multiple grants for which I am a Co-Investigator. I have also received NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI, and the MGH Executive Committee on Research Fund for Medical Discovery. I currently serve as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. I am the previous recipient of the Charles A. King Trust Research Award, and the prestigious AAMC Herbert W. Nickens Faculty Fellowship Award, which recognizes a junior faculty member who demonstrates leadership potential in addressing inequity in health care. I have published my work and editorials in leading journals such as NEJM, Lancet Public Health, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases, and Annals of Internal Medicine. My work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.
Education
- George Washington University School of Medicine, MD
- Washington University in St. Louis, BA
Publications
- Published on 4/2/2024
Montoya ID, Watson C, Aldridge A, Ryan D, Murphy SM, Amuchi B, McCollister KE, Schackman BR, Bush JL, Speer D, Harlow K, Orme S, Zarkin GA, Castry M, Seiber EE, Barocas JA, Linas BP, Starbird LE. Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study. Addict Sci Clin Pract. 2024 Apr 02; 19(1):23. PMID: 38566249.
Read at: PubMed - Published on 3/25/2024
Bartholomew TS, Plesons M, Serota DP, Alonso E, Metsch LR, Feaster DJ, Ucha J, Suarez E, Forrest DW, Chueng TA, Ciraldo K, Brooks J, Smith JD, Barocas JA, Tookes HE. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addict Sci Clin Pract. 2024 Mar 25; 19(1):21. PMID: 38528570.
Read at: PubMed - Published on 3/13/2024
Wang J, Bernson D, Erdman EA, Villani J, Chandler R, Kline D, White LF, Barocas JA. Intersectional inequities and longitudinal prevalence estimates of opioid use disorder in Massachusetts 2014-2020: a multi-sample capture-recapture analysis. Lancet Reg Health Am. 2024 Apr; 32:100709. PMID: 38510791.
Read at: PubMed - Published on 3/12/2024
Nall SK, Jurecka C, Ammons A, Rodriguez A, Craft B, Waleed C, Dias D, Henderson J, Boyer J, Yamkovoy K, Swathi PA, Patil P, Behne F, LeMasters K, Brinkley-Rubinstein L, Barocas JA. Identifying structural risk factors for overdose following incarceration: a concept mapping study. Health Justice. 2024 Mar 12; 12(1):11. PMID: 38472497.
Read at: PubMed - Published on 12/19/2023
Doogan NJ, Mack A, Wang J, Crane D, Jackson R, Applegate M, Villani J, Chandler R, Barocas JA. Correction to: Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method. Am J Epidemiol. 2023 Dec 19. PMID: 38140815.
Read at: PubMed - Published on 9/26/2023
Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin GA, Starbird L, Linas BP, Barocas JA, Morgan JR. Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths. J Addict Med. 2024 Jan-Feb 01; 18(1):13-18. PMID: 37768777.
Read at: PubMed - Published on 9/26/2023
Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods. Epidemiology. 2023 Nov 01; 34(6):841-849. PMID: 37757873.
Read at: PubMed - Published on 9/18/2023
Savinkina A, Jurecka C, Gonsalves G, Barocas JA. Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study. Int J Drug Policy. 2023 Nov; 121:104175. PMID: 37729682.
Read at: PubMed - Published on 9/5/2023
Flam-Ross JM, Marsh E, Weitz M, Savinkina A, Schackman BR, Wang J, Madushani RWMA, Morgan JR, Barocas JA, Walley AY, Chrysanthopoulou SA, Linas BP, Assoumou SA. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder. JAMA Netw Open. 2023 Sep 05; 6(9):e2329583. PMID: 37703018.
Read at: PubMed - Published on 6/28/2023
Palis H, Barocas JA, Moe J, Scow M, Sedgemore KO, Slaunwhite AK, Buxton JA. Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply. Int J Drug Policy. 2023 Aug; 118:104110. PMID: 37390695.
Read at: PubMed
View 85 more publications: View full profile at BUMC